Short rationale of the funded hub: "Pharmaceutical products are not designed to be personalized – despite of the fast development of life-saving new medicines (active compounds), biomedicine and improved diagnostic tools, the most common customer product for treatment is based on tablets with a fixed dose of the active compound. Still, after 200 years of the first patent on a tablet machine, tablets and other solid dosage forms are covering more than 60% of the pharmaceutical